Immutep Quarterly Activities Report

NEXT STORY
ONO Receives a Manufacturing and Marketing Approval of Adlumiz® (Anamorelin), a Ghrelin Receptor Agonist for the Treatment of Cancer Cachexia in Japan
PREV STORY
Predictive Oncology Announces Closing of $2.2 Million Registered Direct Offering Priced At-the-Market under Nasdaq Rules
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

$3.72 Bn Bioanalytical Testing Services Market by Type, Application, End-user and Region – Forecast to 2025

author_avatar
NASDAQ Market News

EyePoint Pharmaceuticals Announces Completion of Enrollment of Phase 1 DAVIO Clinical Trial of EYP-1901 for the Potential Treatment of Wet AMD

author_avatar
NASDAQ Market News

Air Methods’ EVP, Chris Myers, Appointed to Air Ambulance and Patient Billing Advisory Committee

author_avatar
NASDAQ Market News